Patient Group Direction: Ciprofloxacin under 12 further supply (Anthrax)

Document first published:
Page updated:
Topic:
,
Publication type:

Patient Group Direction (PGD) for further supply of ciprofloxacin tablets or suspension to children aged under 12 years of age with known or suspected exposure to anthrax.

Document

Patient Group Direction: Ciprofloxacin under 12 further supply (Anthrax)

Patient Group Direction: Ciprofloxacin under 12 further supply (Anthrax)

  • Microsoft Word
  • 169 KB
  • 14 pages